Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study

AIMS: This three-year follow-up study aimed to elucidate whether sodium-glucose cotransporter-2 inhibitors (SGLT2is) have any protection against diabetic neuropathy and nephropathy in patients with type 2 diabetes via reducing variability in glycemia and extraglycemic factors or their averages. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishibashi, Fukashi, Kosaka, Aiko, Tavakoli, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247156/
https://www.ncbi.nlm.nih.gov/pubmed/35784562
http://dx.doi.org/10.3389/fendo.2022.864332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247156/
https://www.ncbi.nlm.nih.gov/pubmed/35784562
http://dx.doi.org/10.3389/fendo.2022.864332

Ejemplares similares